Development and validation of a prediction model for tocilizumab failure in hospitalized patients with SARS-CoV-2 infection

This secondary analysis of the TESEO cohort (n=266) found this model’s scores can assist clinicians in identifying, early after tocilizumab administration, patients who are likely to progress to mechanical ventilation or death to allow selection for eventual rescue therapies.

Source:

PLOS ONE